Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE)

NCT05995600 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05995600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05995600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE)
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 20, 2024
Completion date
June 30, 2029
Enrollment
200 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome, cardiovascular diseases, cerebrovascular disease, ischemic stroke, major bleed, transient ischemic attack